Second Messenger Nucleotides of Enterococcus faecalis

ABSTRACT Enterococci are the 3rd most common cause of hospital-acquired infections and a major public health threat due to the continuous rise of multidrug-resistant (MDR) isolates. Because the pathogenic potential of enterococci is closely linked to their ubiquitous stress resilience, work in our lab aims to identify and dissect the

mechanisms that allow Enterococcus faecalis, the most prevalent enterococcal species of human infections, to survive in the hostile host environment. Second messenger nucleotides such as (p)ppGpp (the effector molecule of the stringent response) and c-di-AMP are produced by bacteria in response to internal or external

stimuli, playing major roles in the regulation of processes associated with cell homeostasis and virulence. In addition, cyclic nucleotides such as c-di-AMP act as agonists of the innate immune response of mammalians by stimulating a potent STING-dependent type I interferon response. Of interest, previous investigations have

shown that the c-di-AMP and (p)ppGpp networks are interconnected in other bacteria, but a clear understanding of the mechanics and physiological significance of this interaction are still lacking. In previous studies, we discovered that E. faecalis depends on small amounts of (p)ppGpp to maintain a balanced

metabolism and to respond to external cues in an accurate and timely manner. We also found that lack of (p)ppGpp greatly increases antibiotic sensitivity and attenuates the virulence of E. faecalis. More recently, we showed that c-di-AMP is also critical to E. faecalis pathophysiology and that either accumulation or lack of c-

di-AMP can drastically impair the virulence potential of E. faecalis. The goals of this application are: (i) to probe the multifaceted roles played by c-di-AMP during infection using a catheter-associated urinary tract infection (CAUTI) mouse model that recapitulates many of the clinical characteristics of the disease in humans,

(ii) to identify and characterize the c-di-AMP binding/effector proteins in E. faecalis, and (iii) to investigate how integration of the c-di-AMP and (p)ppGpp networks controls specific processes that promote bacterial fitness and then determine how this association contributes to E. faecalis pathophysiology. This conceptually

innovative application builds on our extensive preliminary data and the complementary expertise and solid track record of our research team in each specific area of this application. Significance of the proposed studies lies in unravelling the multifaceted role of c-di-AMP in host-pathogen interactions, uncovering the

scope of c-di-AMP regulation in a major MDR pathogen, and shedding new light onto the intricate relationship between c-di-AMP and (p)ppGpp signaling networks. Given the central role of second messenger nucleotides in bacterial pathogenesis, a better understanding of how they modulate cell physiology based on the identification

and characterization of their mechanisms of action and effectors can facilitate the rational design of new antimicrobial therapies.